The U.S. Federal Trade Commission filed a lawsuit against telehealth provider Hims & Hers Health over deceptive business practices and data handling.
The legal action targets the intersection of digital health and consumer privacy. Because telehealth services handle highly sensitive medical information, allegations of improper data sharing and predatory billing can undermine trust in the broader remote care industry.
The FTC was joined in the lawsuit by the Utah Department of Commerce and Los Angeles County [1]. Regulators said that Hims & Hers misled consumers regarding the nature of recurring subscriptions [1]. This suggests that customers were signed up for automatic payments without clear or honest disclosure of the terms.
Beyond billing disputes, the lawsuit alleges that the company improperly shared sensitive health data with advertising partners [2]. The complaint asserts that these actions violated consumer-protection laws designed to safeguard private medical information from being used for commercial gain.
The market reacted quickly to the legal filings. The company's stock price fell on July 29, 2026 [1], immediately following the announcement of the lawsuit. Investors responded to the potential for significant fines and the possibility that the company may be forced to alter its primary revenue-generating subscription models.
This coordinated effort between federal authorities and local governments in Utah and California indicates a broad regulatory push to clean up the telehealth sector. The lawsuit focuses on two distinct but related failures: the lack of transparency in financial transactions, and the failure to maintain the confidentiality of patient records [1], [2].
“The FTC filed a lawsuit alleging that Hims & Hers misled consumers about recurring subscriptions”
This lawsuit signals a tightening of regulatory oversight for the telehealth industry, which has grown rapidly with less scrutiny than traditional brick-and-mortar medicine. By targeting both 'dark patterns' in subscription billing and the monetization of health data, the FTC is establishing a precedent that digital health platforms must adhere to the same consumer protection and privacy standards as traditional healthcare providers.
